278 related articles for article (PubMed ID: 20717951)
1. Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis.
Cingi C; Gunhan K; Gage-White L; Unlu H
Laryngoscope; 2010 Sep; 120(9):1718-23. PubMed ID: 20717951
[TBL] [Abstract][Full Text] [Related]
2. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
4. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
[TBL] [Abstract][Full Text] [Related]
5. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
[TBL] [Abstract][Full Text] [Related]
6. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis--a randomized placebo-controlled study.
Li AM; Abdullah VJ; Tsen CS; Au CT; Lam HS; So HK; Chan MH; Leung AW; Chan IH; Lam CW; Ng PC
Pediatr Pulmonol; 2009 Nov; 44(11):1085-92. PubMed ID: 19746439
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.
Nathan RA
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):182-90; quiz 190-1, 232. PubMed ID: 12602664
[TBL] [Abstract][Full Text] [Related]
11. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis.
Wilson AM; Orr LC; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Jan; 31(1):61-8. PubMed ID: 11167952
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast.
Simons FE; Johnston L; Gu X; Simons KJ
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):44-50. PubMed ID: 11206237
[TBL] [Abstract][Full Text] [Related]
13. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
Ciprandi G; Tosca MA; Milanese M; Schenone G; Ricca V
Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
[TBL] [Abstract][Full Text] [Related]
14. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
[TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
18. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of montelukast add-on therapy in allergic rhinitis.
Modgill V; Badyal DK; Verghese A
Methods Find Exp Clin Pharmacol; 2010 Nov; 32(9):669-74. PubMed ID: 21225018
[TBL] [Abstract][Full Text] [Related]
20. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.
Razi C; Bakirtas A; Harmanci K; Turktas I; Erbas D
Ann Allergy Asthma Immunol; 2006 Dec; 97(6):767-74. PubMed ID: 17201236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
